Katerina Stravoravdi
Psychologist, CBT therapist, PhD Candidate and Clinical Trial Coordinator at the Clinical Research Unit, Papageorgiou General Hospital, School of Medicine, Aristotle University of Thessaloniki.
Aikaterini Stravoravdi is a licensed Psychologist, CBT therapist, PhD Candidate and Clinical Trial Coordinator at the Clinical Research Unit, Papageorgiou General Hospital, School of Medicine, Aristotle University of Thessaloniki. Her doctoral research focuses on neuropsychological assessment, ethical issues and the nocebo effect in adults participating in clinical trials. She is actively involved in Phase II-III clinical trials, with expertise in participant assessment, psychometrics, safety monitoring, eCRF management and ICH-GCP compliant trial coordination. She holds a MSc in Clinical Mental Health and a diploma in Science of Psychology.
Her research interests lie at the intersection of clinical psychology, neuropsychology, bioethics, clinical pharmacology and CNS clinical trial methodology. A central strand of her work examines cognitive safety, vaccine hesitancy, nocebo mechanisms, digital mental health tools and neuropsychological outcomes in clinical research. She has also contributed to research on psychedelic-assisted therapy and currently participates as a Lead Facilitator in a multinational Phase 3 clinical trial evaluating CYB003 for Major Depressive Disorder.
She is an active member of international research networks and societies, including ECNP, ISCTM, COST Action CA21152 and the Hellenic Society of Basic and Clinical Pharmacology. Her publications include work on vaccine hesitancy, RSV-related neurological complications, AI/NLP approaches in mental health, creativity and resilience platforms and neuropsychological research